In the specialized field of biochemical research, the AC253 peptide has garnered significant attention due to its unique structural characteristics and its role in receptor modulation studies. As someone who follows advancements in peptide science, I have found the investigation into this specific sequence to be particularly fascinating, especially regarding how it interacts with cellular pathways.
Understanding the AC253 Peptide Structure
Th AC 253 e AC253 molecule is fundamentally a 24-amino acid peptide, originally derived from the 8-32 fragment of the salmon calcitonin hormone. This engineered peptide sequence is widely recognized in scientific literature for its role as a selective amylin (AMY3) receptor antagonist. Because it is a polypeptide, its stability and binding affinity are core subjects in laboratory assessments.
When discussing this compound, it is important to distinguish between the linear form and the cyclic AC253 variant. The latter, often referred to as cAC 253, has been engineered to provide enhanced potency; specifically, res Novel Amylin Analogues Reduce Amyloid-β Cross- ea ac253 peptide vorkommen peptides rch indicates that cAC 253 can be threefold more potent in inhibiting amylin-evoked cAMP increases Cyclic AC253, a novel amylin receptor antagonist, improves compared to its linear counterpart.
Mechanisms and Research Applications
The primary utility of the Amylin Antagonist AC253 Peptide lies in its ability to modulate the amylin receptor, which is often studied alongside the amylin, amide, rat ligand. Laboratory studies have consistently demonstrated that AC 253 is an amylin (AMY3) receptor antagonist capable of blocking various intracellular signaling cascades.
For those analyzing the effects of the peptide in controlled environments, the following points are frequently cited:
* Signaling Inhibition: It effectively blocks adrenomedullin-stimulated cAMP production in vitro.
* Intracellular Regulation: It helps researchers investigate th by GL Dharmaraj·2022·Cited by 10—Type 2 diabetes related human islet amyloidpolypeptide(hIAPP) plays a dual role in Alzheimer's disease (AD). hIAPP has neuroprotective effects in AD mouse Read more e inhibition of calcium influx and the activation of kinases such as PKA, MAPK, and Akt.
* Neuroprotective Studies: A major focus of current research involves how this peptide provides neuroprotection against amyloid beta (Aβ)-induced cell death and toxicity. By preventing the Aβ-induced increase in by R Soudy·2019·Cited by 39—Amylin receptor antagonist, AC253,is a 24-amino acid peptide, originally derived from 8-32 fragment of salmon calcitonin hormone. Data from our Read more intracellular Ca2+, it serves as a valuable tool for understanding neuronal resilience.
Practical Considerations for Research
When sourcing this material, researchers often look for high-purity synthesized peptides. The compound, commonly identified by its CAS number 151804-79-4, requires strict storage conditions—typically at -20°C in a dry, light-protected environment—to maintain its structural integrity.
It is also worth noting that AC 253, an amylin antagonist, is frequently compared to other peptides in competitive binding assays. For instance, studies involving labeled AC253 peptide have been instrumental in confirming the specificity of binding at the amylin receptor site. Whether utilizing the linear form or the more robust cyclic version, the focus remains on its high selectivity and its role as a powerful tool in receptor pharmacology.
Final Thoughts
The evolution of research surroundi AC 253 | CAS NO.:151804-79-4 ng AC 253 reflects a broader interest in how pancreatic hormones cosecreted with insulin interact with receptors throughout the body. As an observer of these developments, it is clear that the precision with which cAC 253 is an antagonist of the amylin receptor makes it an indispensable asset for those exploring the complex signaling pathways associated with amyloid-beta toxicity and cellular health.
*Disclaimer: This content is for informational purposes related to biochemical research only. It does not provide medical advice, diagnosis, or treatment recommendations.*